Rein Therapeutics, Inc. (RNTX) Capital expenditures 2016–2022
Rein Therapeutics, Inc. (RNTX) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$157,000FY2022 · since FY2016: $94,000 → $157,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | $157,000 | +3040.0% |
| FY2021 | $5,000 | -96.7% |
| FY2020 | $151,000 | -96.6% |
| FY2019 | $4.4M | +3014.8% |
| FY2018 | $142,000 | — |
| FY2016 | $94,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice